Technical Analysis for CREO - Creo Medical Group Plc

Grade Last Price % Change Price Change
D 35.10 1.01% 0.35
CREO closed up 1.01 percent on Wednesday, April 24, 2024, on 45 percent of normal volume. It ran into resistance at its 50 day moving average. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Flat Flat Up

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
200 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
Earnings Movers Other 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
NR7 Range Contraction 1.01%
NR7-2 Range Contraction 1.01%
Narrow Range Bar Range Contraction 1.01%
Inside Day Range Contraction 1.01%

   Recent Intraday Alerts

Alert Time
2x Volume Pace about 23 hours ago
1.5x Volume Pace about 23 hours ago
20 DMA Support about 23 hours ago
10 DMA Support about 23 hours ago
200 DMA Support about 23 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Creo Medical Group Plc Description

Creo Medical Group plc is a United Kingdom-based medical device company. The Company focuses on the field of surgical endoscopy. The Company focuses on the development and commercialization of minimally invasive surgical devices, initially in the area of gastrointestinal (GI) surgery and lung cancer. The Company has developed CROMA, which is an electrosurgical platform that can deliver microwave and bipolar radiofrequency through a single accessory port. The Company's surgical system CROMA combines bipolar radiofrequency for localized cutting and microwave energy for controlled coagulation, which provides physicians with simplified and controlled surgical solutions. The Company's pipeline portfolio of instruments is targeted at three therapeutic endoscopic specialties: lower GI; lung/bronchoscopy and upper GI.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Energy Gas Medicine Cancer Pipe Surgery Radio Medical Device Microwave IPO Lung Cancer Surgical Solutions

Is CREO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 50.0
52 Week Low 22.718
Average Volume 841,216
200-Day Moving Average 35.24
50-Day Moving Average 35.14
20-Day Moving Average 35.73
10-Day Moving Average 34.92
Average True Range 1.45
RSI (14) 46.24
ADX 14.44
+DI 27.35
-DI 20.62
Chandelier Exit (Long, 3 ATRs) 36.65
Chandelier Exit (Short, 3 ATRs) 37.35
Upper Bollinger Bands 38.89
Lower Bollinger Band 32.56
Percent B (%b) 0.4
BandWidth 17.71
MACD Line -0.39
MACD Signal Line -0.22
MACD Histogram -0.1717
Fundamentals Value
Market Cap 126.88 Million
Num Shares 361 Million
EPS -0.11
Price-to-Earnings (P/E) Ratio -319.09
Price-to-Sales 4.47
Price-to-Book 1.83
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 38.10
Resistance 3 (R3) 38.40 37.70 37.60
Resistance 2 (R2) 37.70 36.94 37.55 37.43
Resistance 1 (R1) 36.40 36.46 36.05 36.10 37.27
Pivot Point 35.70 35.70 35.53 35.55 35.70
Support 1 (S1) 34.40 34.94 34.05 34.10 32.93
Support 2 (S2) 33.70 34.46 33.55 32.77
Support 3 (S3) 32.40 33.70 32.60
Support 4 (S4) 32.10